The global defibrillators market size was valued at USD 12.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.20% from 2023 to 2030. Increasing product developments, rising incidence of sudden cardiac arrest, growing awareness among the general public, and supportive initiatives by governments and healthcare organizations are some of the key factors fueling the growth of this market. In May 2021, an Australian company- Rapid Response Revival Research Ltd. received a CE mark for its CellAED-the world’s first personal AED for home use. This supported the company’s growth strategy.
The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued to create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due to a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due to the pandemic.
Death due to sudden cardiac arrest is attributable to nearly half of all deaths from cardiovascular diseases despite developments in prevention and treatment. This is anticipated to drive innovation in the market while increasing demand for both ICDs and external defibrillators. Ami Italia, for instance, manufactures a range of defibrillators as part of its Saver One series, Geo Saver series, and Smarty Saver series. The Smarty Series, for example, can be used by anyone in medical and nonmedical fields in various settings, such as ambulances, emergency rooms, and public or private places. Microport, on the other hand, is the leader in the cardiac rhythm management market in China. It registered 95% growth in revenue during H1 2021 in the Chinese market owing to a wide portfolio and robust product pipeline.
Pandemic Impact |
Post COVID Outlook |
The defibrillators market experienced a negative growth rate of 7.20% from 2019 to 2020, due to the postponement of cardiovascular procedures categorized as elective surgeries |
The market is expected to gain pace in 2021, by reaching USD 11.8 billion at a year-on-year growth of 8.15% |
Key market participants such as Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., and Defibtech, LLC, experienced negative growth in 2020 |
Market players are expected to focus on investing in rapid defibrillation devices for home healthcare purposes. The segment of AEDs is also expected to experience growth in the coming years |
Boston Scientific Corporation registered a decline of 12.12% in its cardiac rhythm management segment, which consists of defibrillators amongst other cardiovascular devices |
|
Growing awareness regarding cardiovascular events in developing markets is another key driver for the market. In the UAE, the number and usage of defibrillators are notably low. However, the presence of local distributors and increasing initiatives to raise awareness regarding cardiac health are expected to contribute to the market growth in the coming years. In September 2019, the Dubai Corporation for Ambulance Services (DCAS) announced that it would donate 80 AEDs to various places of worship, private and government entities, and other venues in the city, in addition to training chosen volunteers. This was part of the My City Saves Me campaign to create and connect a pool of trained volunteers through DCAS’ Help Me app. Some of the leading distributors active in the UAE include Defibrillator Dubai, Gulf AED, AED Dubai, and Atlas Medical Group.
Hospitals held the largest revenue share of over 80.0% in 2022. This is owing to the higher number of cardiac patients received in hospitals and surgeries performed in hospital settings. Both ICDs and external defibrillators are increasingly used in hospitals to deliver treatment to patients of sudden cardiac arrest and for other indications. Boston Scientific, for example, reported a distribution of around 659,000 ICDs globally as of January 2021. This number notably increased by 59,000 when compared to the 600,000 ICDs distributed by January 2020 indicating a high demand.
The public access market segment is anticipated to register the fastest growth rate of about 10% over the forecast period due to the rising initiatives to increase the availability of public access AEDs, train personnel, and improve response to sudden cardiac arrest events. In January 2020, Global Times reported that several tourist cities, first-tier cities, and coastal provinces across China have initiated accelerated AED deployment since 2019. Hangzhou also became the first city in China to mandate the dissemination of AEDs at airports, metro stations, law enforcement vehicles, ships, and other public places.
Implantable cardioverter defibrillators (ICDs) dominated the market by product in 2022. The key factors driving this segment include the growing adoption of these devices due to the high prevalence of cardiovascular diseases, the high geriatric population in key markets, and growing product improvements by major companies. Medtronic, for instance, reported continued acceptance and expansion of its MRI-compatible Claria CRT-D devices in 2020. This was in addition to strong growth recorded for its Crome & Cobalt portfolio of CRT-Ds and ICDs.
The external defibrillators segment is anticipated to register the fastest growth rate of 9.0% over the forecast period. This is due to technological advancements and initiatives promoting access to AEDs in public places. A bill to enhance availability and access to AEDs (Public Access) in the U.K. is in the pipeline. If the bill is cleared, it will become mandatory to install defibrillators at public places, thus boosting the demand for AEDs. Favorable regulatory policies and initiatives by public and private health organizations to promote public access to defibrillators already exist in several key markets, including the U.S., Canada, Italy, Japan, Australia, and China.
North America held the largest revenue share of more than 35.0% in 2022. The growth of the North American market can be attributed to the initiatives by key players, favorable regulations, and technologically advanced healthcare facilities in the U.S. and Canada. Boston Scientific, for instance, reported that it had distributed about 33,000 of its CRT-Ds line-up including Resonate, Autogen, Dynagen, Incepta, and Cognis devices worldwide in 2020. Out of these, 16,500 were registered in the U.S. alone indicating a high adoption rate.
Asia Pacific is projected to expand at the fastest CAGR of 8.1% over the forecast period. This is owing to developing healthcare infrastructure, high patient population, and prevalence of cardiac diseases. The regional growth is spearheaded by the Japanese market owing to the high penetration of defibrillators and supportive policies. In fact, Nihon Kohden, a market leader in Japan registered over USD 66,000 sales of manual external defibrillators in 2020.
The market has been characterized by intense competition. Market players incorporate various strategic initiatives to increase their market share. These include product development, regional expansion, partnerships and collaborations, and mergers & acquisitions. For instance, in August 2019, ZOLL Medical Corporation acquired Cardiac Science Corporation- a leading AEDs manufacturer in the U.S. This strengthened ZOLL's AED product portfolio and accelerated the global expansion plans of the company’s AED business. In February 2020, Abbott, on the other hand, received CE Mark for its Gallant ICDs and CRT-D devices. This supported the company’s growth objectives. Some prominent players in the global defibrillator market include:
Medtronic
Abbott
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
MicroPort Scientific Corporation
Koninklijke Philips N.V.
Stryker
ZOLL Medical Corporation (Asahi Kasei)
Nihon Kohden Corporation
Progetti Srl
Schiller AG
MS Westfalia GmbH
AMI Italia
AXION Ltd.
Bexen Cardio
MicroPort Scientific Corporation
Asahi Kasei Corporation
CU Medical Systems
METsis Medikal
Mediana Co. Ltd.
Mindray Medical International Ltd.
Progetti SRL – Medical Equipment Solutions
BPL Medical Technologies
Metrax GmbH – PRIMEDIC
Element Science Inc.
Avive Solutions Inc.
Jeevtronics Pvt. Ltd.
HeartHero Inc.
Shenzhen Comen Medical Instruments Ltd.
Report Attribute |
Details |
Market size value in 2023 |
USD 12.8 billion |
Revenue forecast in 2030 |
USD 20.8 billion |
Growth rate |
CAGR of 7.20% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2017 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million/billion & CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, end-use, region |
Regions covered |
North America; Europe; Asia Pacific; Latin America; MEA |
Country Scope |
U.S.; Canada; U.K.; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Thailand; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Medtronic; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation (Asahi Kasei); Nihon Kohden Corporation; Progetti Srl; Schiller AG; MS Westfalia GmbH; AMI Italia; AXION Ltd0.; Bexen Cardio; MicroPort Scientific Corporation; Asahi Kasei Corporationz; CU Medical Systems; METsis Medikal; Mediana Co. Ltd.; Mindray Medical International Ltd.; Progetti SRL – Medical Equipment Solutions; BPL Medical Technologies; Metrax GmbH – PRIMEDIC; MS Westfalia GmbH; Bexen Cardio; Axion Medical Equipment Ltd.; Element Science Inc.; Avive Solutions Inc.; Jeevtronics Pvt. Ltd.; HeartHero Inc.; Shenzhen Comen Medical Instruments Ltd. |
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2030. For the purpose of this report, Grand View Research has segmented the global defibrillators market report on the basis of product, end use, and region:
Product Outlook (Revenue, USD Million, 2017 - 2030)
Implantable Cardioverter Defibrillators (ICD)
S-ICD
T-ICD
Single Chamber
Dual Chamber
CRT-D
External Defibrillators (ED)
Manual ED
Automated ED
Wearable Cardioverter Defibrillators
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Hospital
Pre Hospital
Public Access Market
Alternate Care Market
Home Healthcare
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Colombia
MEA
South Africa
Saudi Arabia
UAE
Kuwait
b. The global defibrillator market size was estimated at USD 12.0 billion in 2022 and is expected to reach USD 12.8 billion by 2023.
b. The global defibrillator market is expected to grow at a compound annual growth rate of 7.2% from 2023 to 2030 to reach USD 20.8 billion by 2030.
b. North America dominated the defibrillator market with a share of over 35% in 2022. The large share of the North American region can be attributed to initiatives by key players, favorable regulations, high prevalence of cardiovascular diseases, and technologically advanced healthcare facilities in the U.S. and Canada.
b. Some key players operating in the global defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; BIOTRONIK SE & Co. KG; MicroPort Scientific Corporation; Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation (Asahi Kasei); Nihon Kohden Corporation; and Schiller AG.
b. Key factors that are driving the global defibrillator market growth include increasing product developments, high incidence of sudden cardiac arrest, rising awareness among the general public, and supportive initiatives by governments & healthcare organizations.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.